WB
Publications
360
Views
167,766
Downloads
18,169
Supervised works
3
Items per page
1 - 360 of 360
Title Published in Access level OA Policy Year Views Downloads
Sex Disparities of Health-related Quality of Life in Moderate to Severe Psoriasis : A Real-world Analysis from the Swiss Psoriasis Registry (SDNTT)Acta dermato-venereologica
accessLevelPublic
2025 5 10
Approved systemic drugs needed for dermatosis like alopecia areata, hidradenitis and vitiligo : A SPIN-FRT evaluationJournal of the European Academy of Dermatology and Venereology
accessLevelRestricted
2025 2 0
Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors : 2024 updateAnnals of the rheumatic diseases
accessLevelPublic
2025 2 23
Bimekizumab Efficacy in Psoriasis by Subgroups : Post Hoc Analysis of Phase 3/3b Clinical TrialsDermatology and therapy
accessLevelPublic
2025 2 18
Treatment of psoriasis with biologic and non-biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression : Recommendations from a SPIN-FRT expert consensusJournal of the European Academy of Dermatology and Venereology
accessLevelRestricted
2025 61 0
Bimekizumab Efficacy and Safety in Patients with Psoriatic Arthritis with Substantial Skin and Nail Psoriasis to 1 YearDermatology and therapy
accessLevelPublic
2025 3 5
The ‘Mono-Side’ of Cutaneous Adverse Drug ReactionsJEADV. Journal of the European Academy of Dermatology and Venereology
accessLevelRestricted
2025 14 0
Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics : post hoc analysis of a phase 3 studyClinical rheumatology
accessLevelPublic
2024 92 61
Advances in Psoriatic Disease Research : Insights From GRAPPA Pilot Research AwardeesThe journal of rheumatology
accessLevelRestricted
2024 38 0
Basic Susceptibility of Patients with Psoriasis under Systemic Therapy for Respiratory Infections : Data from the German Psoriasis Registry PsoBestJournal of clinical medicine
accessLevelPublic
2024 38 78
Efficacy and safety of pharmacological treatment of psoriatic arthritis : a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritisAnnals of the rheumatic diseases
accessLevelPublic
2024 53 166
Predicting Psoriatic Arthritis in Psoriasis Patients - A Swiss Registry StudyJournal of psoriasis and psoriatic arthritis
accessLevelPublic
2024 32 79
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies : 2023 updateAnnals of the rheumatic diseases
accessLevelPublic
2024 61 310
Psoriasis localization patterns in the Swiss Psoriasis Registry (SDNTT) over 11 years : an analysis by sex and ageArchives of dermatological research
accessLevelPublic
2024 35 29
Impact dermatologique du changement climatiqueRevue médicale suisse
accessLevelPublic
2024 55 19
Sex differences in adverse events from systemic treatments for psoriasis : A decade of insights from the Swiss Psoriasis Registry (SDNTT)Journal of the European Academy of Dermatology and Venereology
accessLevelRestricted
2023 76 0
Statins and psoriasis : Position statement by the Psoriasis Task Force of the European Academy of Dermatology and VenerologyJournal of the European Academy of Dermatology and Venereology
accessLevelRestricted
2023 90 0
EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritisAnnals of the rheumatic diseases
accessLevelPublic
2023 129 137
Revisiting the interleukin 17 family of cytokines in psoriasis : pathogenesis and potential targets for innovative therapiesFrontiers in immunology
accessLevelPublic
2023 71 205
Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience : Analysis of the Phase 3, Randomized, Placebo-Controlled DISCOVER-1 StudyACR open rheumatology
accessLevelPublic
2023 111 135
Adipose-derived stromal cells within a gelatin matrix acquire enhanced regenerative and angiogenic properties: a pre-clinical study for application to chronic woundsBiomedicines
accessLevelPublic
2023 161 84
Inflammation modulates intercellular adhesion and mechanotransduction in human epidermis via ROCK2iScience
accessLevelPublic
2023 99 118
Full-body blue light irradiation as treatment for atopic dermatitis : a randomized sham-controlled clinical trial (AD-Blue)Journal der Deutschen Dermatologischen Gesellschaft
accessLevelPublic
2023 70 161
Parlons du pruritRevue médicale suisse
accessLevelPublic
2023 140 39
Paradoxical nail psoriasis induced by the IL-17A inhibitor ixekizumab in palmoplantar pustulosisInternational journal of dermatology
accessLevelRestricted
2023 66 0
Safety of Guselkumab With and Without Prior Tumor Necrosis Factor Inhibitor Treatment : Pooled Results Across 4 Studies in Patients With Psoriatic ArthritisJournal of rheumatology
accessLevelPublic
2023 88 69
Elevating the Standard of Care for Patients with Psoriasis : 'Calls to Action' from Epicensus, a Multistakeholder Pan-European InitiativeDermatology and therapy
accessLevelPublic
2023 110 42
Mechanotransduction in Skin InflammationCells
accessLevelPublic
2022 194 462
IL-25 participates in keratinocyte-driven dermal matrix turnover and is reduced in systemic sclerosis epidermisRheumatology
accessLevelRestricted
2022 321 5
La dermatologie à l’ère du Covid-19Revue médicale suisse
accessLevelPublic
2022 386 68
Pathogenesis-oriented therapy of psoriasis using biologicsExpert opinion on biological therapy
accessLevelRestricted
2022 170 0
IL ‐38 orchestrates proliferation and differentiation in human keratinocytesExperimental dermatology
accessLevelPublic
2022 268 190
Comparative Effectiveness of Guselkumab in Psoriatic Arthritis: Updates to a Systematic Literature Review and Network Meta-AnalysisRheumatology
accessLevelPublic
2022 164 503
Adipose-Derived Stromal Cells for Chronic Wounds: Scientific Evidence and Roadmap Toward Clinical PracticeStem cells translational medicine
accessLevelPublic
2022 179 196
Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studiesRMD open
accessLevelPublic
2022 254 119
Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic ArthritisThe Journal of rheumatology
accessLevelPublic
2021 318 320
Interleukin-17E, inducible nitric oxide synthase and arginase1 as new biomarkers in the identification of neutrophilic dermatosesClinical and experimental dermatology
accessLevelPublic
2021 169 85
Deutsche S3-Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm – Teil 2: Therapiemonitoring, besondere klinische Situationen und KomorbiditätJournal der Deutschen Dermatologischen Gesellschaft
accessLevelPublic
2021 259 912
Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysisRheumatology
accessLevelPublic
2021 238 479
Dysfunctional keratinocytes increase dermal inflammation in systemic sclerosis. Results from tissue-engineered scleroderma epidermisArthritis and Rheumatology
accessLevelPublic
2021 411 428
German S3-Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm - Part 1: Treatment goals and treatment recommendationsJournal der Deutschen Dermatologischen Gesellschaft
accessLevelPublic
2021 298 144
German S3-Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm - Part 2: Treatment monitoring and specific clinical or comorbid situationsJournal der Deutschen Dermatologischen Gesellschaft
accessLevelPublic
2021 301 315
LOOP, a cross-sectional, observational study investigating the clinical specialty setting as a determinant of disease management in psoriatic arthritis: Subgroup analysis results from JapanPloS one
accessLevelPublic
2021 93 85
Un équilibre à fleur de peauRevue médicale suisse
accessLevelPublic
2021 252 148
Deutsche S3-Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm – Teil 1: Therapieziele und TherapieempfehlungenJournal der Deutschen Dermatologischen Gesellschaft
accessLevelPublic
2021 428 263
Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experiencedRMD open
accessLevelPublic
2021 235 125
Psoriasisarthritis: Relevantes für die dermatologische PraxisDer Hautarzt
accessLevelRestricted
2021 169 0
Psoriasis : pourquoi en parler encore et toujours ?Revue médicale suisse
accessLevelPublic
2021 252 223
Guselkumab: the First Selective IL-23 Inhibitor for Active Psoriatic Arthritis in AdultsExpert review of clinical immunology
accessLevelRestricted
2021 140 0
Psoriasisarthritis : Wichtige Aspekte für die PraxisDer Hautarzt
accessLevelRestricted
2021 127 1
IL-25 (IL-17E) in epithelial immunology and pathophysiologyThe journal of allergy and clinical immunology
accessLevelRestricted
2021 192 0
Voneinander lernen, miteinander behandelnDer Hautarzt
accessLevelPublic
2021 151 91
Dermatologie: Passage de la dermatite atopique au psoriasis - et retourRevue médicale suisse
accessLevelPublic
2021 255 338
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trialLancet. Oncology
accessLevelRestricted
2021 247 0
Circadian clocks guide dendritic cells into skin lymphaticsNature immunology
accessLevelPublic
2021 467 176
Association of sex and systemic therapy treatment outcomes in psoriasis: a two-country, multicentre, prospective, noninterventional registry studyBritish journal of dermatology
accessLevelRestricted
2021 178 0
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statementAnnals of the Rheumatic Diseases
accessLevelPublic
2021 341 269
Disease Characteristics and the Burden of Joint and Skin Involvement Amongst People With Psoriatic Arthritis: A Population SurveyRheumatology and Therapy
accessLevelPublic
2020 207 106
IL-17A in psoriasis and beyond: cardiovascular and metabolic implicationsFrontiers in Immunology
accessLevelPublic
2020 301 213
Targeted cutaneous delivery of etanercept using Er:YAG fractional laser ablationInternational Journal of Pharmaceutics
accessLevelRestricted
2020 329 0
Sex-related impairment and patient needs/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred carePLOS ONE
accessLevelPublic
2020 231 119
Tofacitinib in psoriatic arthritis patients: skin signs and symptoms and health-related quality of life from two randomized phase 3 studiesJournal of the European Academy of Dermatology and Venereology
accessLevelPublic
2020 216 223
Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase ii studyRMD Open
accessLevelPublic
2020 185 76
IL-17E (IL-25) and IL-17A differentially affect the functions of human keratinocytesThe Journal of Investigative Dermatology
accessLevelPublic
2020 490 245
The Janus Kinase inhibitor tofacitinib impacts human dendritic cell differentiation and favours M1 macrophage developmentExperimental Dermatology
accessLevelRestricted
2020 376 0
Association between clinical specialty setting and disease management in patients with psoriatic arthritis: results from LOOP, a cross-sectional, multi-country, observational studyJournal of the European Academy of Dermatology and Venereology
accessLevelRestricted
2020 198 1
Zytokine der IL-17-Familie bei der PsoriasisJournal der Deutschen Dermatologischen Gesellschaft
accessLevelPublic
2020 181 53
Les cytokines IL-17, une famille en expansion utilisée comme cible pour des thérapies anti-inflammatoires innovantesRevue médicale suisse
accessLevelPublic
2020 231 160
Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of ExposureDermatology and Therapy
accessLevelPublic
2020 372 278
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature researchRMD Open
accessLevelPublic
2020 174 148
Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trialLancet
accessLevelPublic
2020 201 95
Cytokines of the IL-17 family in psoriasisJournal der Deutschen Dermatologischen Gesellschaft
accessLevelPublic
2020 206 173
GRAPPA Trainees Symposium 2019: A Report from the GRAPPA 2019 Annual MeetingJournal of rheumatology. Supplement
accessLevelRestricted
2020 194 0
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 updateAnnals of the Rheumatic Diseases
accessLevelPublic
2020 436 221
Disease burden and treatment needs of patients with psoriasis in sexually-sensitive and visible body areas: results from a large-scale survey in routine careEuropean journal of dermatology
accessLevelRestricted
2020 223 0
Traitement des kératoses actiniques : l'embarras du choixRevue médicale suisse
accessLevelRestricted
2020 332 1
Cave linguam – ce qu'on dit (ou écrit) et ce que le public entend…Revue médicale suisse
accessLevelPublic
2019 245 87
Best-practice Indicators in Psoriatic Disease CareJournal of Rheumatology. Supplement
accessLevelRestricted
2019 232 0
Gene-diet interactions associated with complex trait variation in an advanced intercross outbred mouse lineNature Communications
accessLevelPublic
2019 353 354
Regulatory cells in the skin: Pathophysiologic role and potential targets for anti-inflammatory therapiesJournal of Allergy and Clinical Immunology
accessLevelRestricted
2019 273 0
Gender and age significantly determine patient needs and treatment goals in psoriasis - a lesson for practiceJournal of the European Academy of Dermatology and Venereology
accessLevelRestricted
2019 359 0
Cardiovascular Diseases in Psoriasis and Psoriatic ArthritisJournal of Rheumatology. Supplement
accessLevelRestricted
2019 305 0
Composite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase 2 TrialArthritis Care and Research
accessLevelPublic
2019 307 140
Topology of psoriasis in routine care: results from high-resolution analysis of 2009 patientsBritish Journal of Dermatology
accessLevelRestricted
2019 334 0
Linkage between patients' characteristics and prescribed systemic treatments for psoriasis: a semantic connectivity map analysis of the Swiss Dermatology Network for Targeted Therapies registryJournal of the European Academy of Dermatology and Venereology
accessLevelRestricted
2019 303 0
Treatment of Atopic Dermatitis Using a Full-Body Blue Light Device (AD-Blue): Protocol of a Randomized Controlled TrialJMIR Research Protocols
accessLevelPublic
2019 250 328
Interleukin-38 interacts with destrin/actin-depolymerizing factor in human keratinocytesPLOS ONE
accessLevelPublic
2019 381 206
GRAPPA Trainees Symposium 2018: A Report from the GRAPPA 2018 Annual MeetingJournal of Rheumatology. Supplement
accessLevelRestricted
2019 257 0
Autoreactive T-Lymphocytes in Inflammatory Skin DiseasesFrontiers in Immunology
accessLevelPublic
2019 337 212
Un cas de « peau d'orange » sans cancerRevue médicale suisse
accessLevelPublic
2019 1,065 54
IL-17E (IL-25) Enhances Innate Immune Responses during Skin InflammationJournal of Investigative Dermatology
accessLevelRestricted
2019 342 0
Innovation en dermatologie : il est temps de changer de mentalité !Revue médicale suisse
accessLevelPublic
2018 265 87
Patient perceptions of clear/almost clear skin in moderate-to-severe plaque psoriasis: results of the Clear About Psoriasis worldwide surveyJournal of the European Academy of Dermatology and Venereology
accessLevelPublic
2018 396 140
Recognition of early melanoma: a monocentric dermoscopy follow-up study comparing de novo melanoma with nevus-associated melanomaInternational Journal of Dermatology
accessLevelRestricted
2018 370 0
Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and ConsequencesFrontiers in Immunology
accessLevelPublic
2018 342 240
Who will treat inflammatory skin diseases in the year 2020?Journal of the European Academy of Dermatology and Venereology
accessLevelRestricted
2018 284 0
GRAPPA Trainees Symposium 2017: A Report from the GRAPPA 2017 Annual MeetingThe Journal of rheumatology. Supplement
accessLevelRestricted
2018 295 0
The IL-17 Family of Cytokines in Psoriasis: IL-17A and BeyondFrontiers in Immunology
accessLevelPublic
2018 391 356
Roger federer pourrait-il jouer en portant un large sombrero ?Revue médicale suisse
accessLevelRestricted
2018 331 5
Bêtabloquants : un nouveau traitement dermatologique ?Revue médicale suisse
accessLevelPublic
2018 438 656
Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a European expert consensusJournal of the European Academy of Dermatology and Venereology
accessLevelRestricted
2018 432 0
Fumarates – bien plus qu'un additif alimentaireRevue médicale suisse
accessLevelPublic
2018 344 173
S3-Leitlinie zur Therapie der Psoriasis vulgaris Update - Kurzfassung Teil 1 - Systemische TherapieJournal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2018 322 1
Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 studyThe Lancet
accessLevelRestricted
2018 332 0
Low incidence of heparin-induced skin lesions in orthopedic surgery patients with low-molecular-weight heparinsClinical and Experimental Allergy
accessLevelRestricted
2018 342 0
Skin Involvement in Psoriatic Arthritis Worsens Overall Disease Activity, Patient-Reported Outcomes, and Increases Healthcare Resource Utilization: An Observational, Cross-Sectional StudyRheumatology and Therapy
accessLevelPublic
2018 355 161
S3-Leitlinie zur Therapie der Psoriasis vulgaris Update - Kurzfassung Teil 2 - Besondere Patientengruppen und spezielle BehandlungssituationenJournal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2018 320 2
The role of IL-23 and the IL-23/TH 17 immune axis in the pathogenesis and treatment of psoriasisJournal of the European Academy of Dermatology and Venereology
accessLevelPublic
2017 508 893
IL-17A localizes in the exocytic compartment of mast cells in psoriatic skinBritish Journal of Dermatology
accessLevelRestricted
2017 408 2
Unmet Needs in the Field of Psoriasis: Pathogenesis and TreatmentClinical Reviews in Allergy and Immunology
accessLevelRestricted
2017 451 0
Altérations unguéales : à quoi penser dans la pratique courante en médecine générale ?Revue médicale suisse
accessLevelPublic
2017 541 1,224
Benchmarking Care in Psoriatic Arthritis - The QUANTUM Report: A Report from the GRAPPA 2016 Annual MeetingJournal of Rheumatology
accessLevelRestricted
2017 396 0
Overexpression of the human antigen R suppresses the immediate paradoxical proliferation of melanoma cell subpopulations in response to suboptimal BRAF inhibitionCancer Medicine
accessLevelPublic
2017 491 170
New biologics in psoriasis - progress and problemsJournal of the European Academy of Dermatology and Venereology
accessLevelRestricted
2017 367 1
Choisir le bon médicament pour votre patient : evidence vs eminence-based medicineRevue médicale suisse
accessLevelPublic
2017 374 124
"Evergreen" Psoriasis - Neues zu Genetik, Therapie, und überhauptJournal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2017 410 2
Inflammation dependent mTORC1 signaling interferes with the switch from keratinocyte proliferation to differentiationPLOS ONE
accessLevelPublic
2017 470 255
Dermal adipocytes' claim for fame in psoriasisExperimental Dermatology
accessLevelRestricted
2017 580 3
Les indications dermatologiques du laser : au-delà de la cosmétiqueRevue médicale suisse
accessLevelPublic
2017 463 511
In vivo reflectance confocal microscopy: a useful non-invasive tool to assess the response to isolated limb perfusion for superficial pigmented melanoma in-transit metastatic disease. Report of a caseDermatology Parctical and Conceptual
accessLevelRestricted
2017 393 0
Keratinocyte-derived IL-17E contributes to inflammation in psoriasisJournal of investigative dermatology
accessLevelRestricted
2016 662 13
IL-22 capacitates dermal fibroblast responses to TNF in sclerodermaAnnals of the rheumatic diseases
accessLevelRestricted
2016 706 7
Komorbidität bei Psoriasis vulgarisDer Hautarzt
accessLevelRestricted
2016 486 1
Superiority in Quality of Life Improvement of Biologics over Conventional Systemic Drugs in a Swiss Real-Life Psoriasis RegistryDermatology
accessLevelRestricted
2016 547 0
Efficacy and Survival of Systemic Psoriasis Treatments: An Analysis of the Swiss Registry SDNTTDermatology
accessLevelRestricted
2016 499 2
Swiss S1 Guidelines on the Systemic Treatment of Psoriasis VulgarisDermatology
accessLevelRestricted
2016 470 0
Surinfection de plaie chronique par Pseudomonas aeruginosaRevue médicale suisse
accessLevelRestricted
2015 581 2
PsoriasisLancet
accessLevelRestricted
2015 577 8
The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologistsDermatology
2015 457 0
Qualifying unmet needs and improving standards of care in psoriatic arthritisArthritis care and research
accessLevelRestricted
2014 565 0
Epidermal insulin resistance as a therapeutic target in acanthosis nigricans?Acta dermato-venereologica
accessLevelRestricted
2014 533 2
GRAPPA 2013 basic/translational/clinical science update: comorbidity monitoringJournal of rheumatology
accessLevelRestricted
2014 546 0
Safety and efficacy of therapies for skin symptoms of psoriasis in patients with psoriatic arthritis: a systematic reviewJournal of rheumatology
accessLevelRestricted
2014 455 0
'Upgrading' psoriasis responsiblyExperimental dermatology
accessLevelRestricted
2014 561 0
More than skin-deep: the many dimensions of the psoriatic diseaseSchweizerische medizinische Wochenschrift
accessLevelRestricted
2014 544 0
The International Dermatology Outcome Measures initiative as applied to psoriatic disease outcomes: a report from the GRAPPA 2013 meetingJournal of rheumatology
accessLevelRestricted
2014 489 0
Prologue: 2013 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)Journal of rheumatology
accessLevelRestricted
2014 592 1
Reversal of Murine Epidermal Atrophy by Topical Modulation of Calcium SignalingJournal of investigative dermatology
accessLevelPublic
2014 580 145
GRAPPA Fellows Symposium Adjacent to the European Academy of Dermatology and Venereology (EADV) Congress, Istanbul, 2013: a meeting reportJournal of rheumatology
accessLevelRestricted
2014 567 0
German psoriasis registry PsoBest: objectives, methodology and baseline dataJournal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2014 511 0
Héparines et réactions cutanées : du diagnostic à la prise en chargeRevue médicale suisse
accessLevelRestricted
2013 568 1
Mammalian target of rapamycin and its downstream signalling components are activated in psoriatic skinBritish journal of dermatology
accessLevelRestricted
2013 640 1
Erythème scarlatiniforme desquamatif récidivant ou maladie de Féréol-Besnier: une entité peu connueRevue médicale suisse
accessLevelRestricted
2013 977 1
Burden of Disease: Psoriasis and Psoriatic ArthritisAmerican journal of clinical dermatology
accessLevelRestricted
2013 684 1
De la compétition à la concertationRevue médicale suisse
accessLevelRestricted
2013 533 2
High incidence of heparin-induced allergic delayed-type hypersensitivity reactions in pregnancyJournal of allergy and clinical immunology
accessLevelRestricted
2013 624 1
Methylprednisolone Blocks Autoantibody-Induced Tissue Damage in Experimental Models of Bullous Pemphigoid and Epidermolysis Bullosa Acquisita through Inhibition of Neutrophil ActivationJournal of investigative dermatology
accessLevelRestricted
2013 596 1
Heparin-induced skin lesionsLancet
accessLevelRestricted
2012 616 1
Neue Erkenntnisse zu Fumarsaureestern (Fumaderm(R)): Ergebnisse des 2. Experten-WorkshopsJournal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2012 530 0
Application, tolerance and safety of fondaparinux therapy in a German hospital: a prospective single-centre experienceThrombosis research
accessLevelRestricted
2012 630 0
The psoriasis xenograft SCID mouse model : a tool in translational researchBritish journal of dermatology
accessLevelRestricted
2012 661 1
Epidemiology and potential pathomechanisms of cardiovascular comorbidities in psoriasis: a report from the GRAPPA 2010 annual meetingJournal of rheumatology
accessLevelRestricted
2012 649 0
Interleukin-1β interferes with epidermal homeostasis through induction of insulin resistance: implications for psoriasis pathogenesisJournal of investigative dermatology
accessLevelRestricted
2012 601 0
Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectivesCurrent rheumatology reports
2012 616 0
Neutralization of macrophage migration inhibitory factor (MIF) by fully human antibodies correlates with their specificity for the beta-sheet structure of MIFThe Journal of biological chemistry
accessLevelRestricted
2012 619 0
German S3-guidelines on the treatment of psoriasis vulgaris (short version)Archives of dermatological research
accessLevelRestricted
2012 714 0
Jenseits der Immunpathogenese Insulinresistenz und „epidermale Dysfunktion“ / Beyond immunopathogenesis. Insulin resistance and "epidermal dysfunction"Der Hautarzt
accessLevelRestricted
2012 621 0
Moderne Psoriasistherapie: Evidenzbasiert, patientengerecht, zielorientiert / Modern therapy of psoriasis : evidence-based, patient-centered, goal-orientedDer Hautarzt
accessLevelPublic
2012 584 360
PsoriasisDer Hautarzt
accessLevelRestricted
2012 650 4
S3 - Guidelines on the treatment of psoriasis vulgaris (English version). UpdateJournal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2012 721 0
Perspective: Don't be superficialNature
accessLevelPublic
2012 559 319
Reduced TRPC channel expression in psoriatic keratinocytes is associated with impaired differentiation and enhanced proliferationPloS one
accessLevelPublic
2011 659 362
Cardiovascular comorbidities in psoriasis and psoriatic arthritis: pathogenesis, consequences for patient management, and future research agenda: a report from the GRAPPA 2009 annual meetingJournal of rheumatology
accessLevelRestricted
2011 619 0
Systemic antipsoriatic therapy may reverse endothelial dysfunctionBritish journal of dermatology
accessLevelRestricted
2011 568 0
S3-Leitlinie zur Therapie der Psoriasis vulgaris Update 2011Journal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2011 561 0
The risk for cross-reactions after a cutaneous delayed-type hypersensitivity reaction to heparin preparations is independent of their molecular weight: a systematic reviewContact dermatitis
accessLevelRestricted
2011 622 0
PAX2 regulates ADAM10 expression and mediates anchorage-independent cell growth of melanoma cellsPloS one
accessLevelPublic
2011 666 403
Changes in the sex hormone profile of male patients with moderate-to-severe plaque-type psoriasis under systemic therapy: results of a prospective longitudinal pilot studyArchives of dermatological research
accessLevelRestricted
2011 679 0
Endogenous mu-opioid peptides modulate immune response towards malignant melanomaExperimental dermatology
accessLevelRestricted
2011 550 1
Neue Erkenntnisse zu Fumarsaureestern (Fumaderm((R))): Ergebnisse eines Experten-WorkshopsJournal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2011 681 0
Microdialysis documents changes in the micromilieu of psoriatic plaques under continuous systemic therapyExperimental dermatology
accessLevelRestricted
2011 605 0
Clinical long-term studies: data collection and assessmentJournal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2011 588 0
A 41 year old man with an itchy rashBMJ. British medical journal
2011 578 0
Therapy of psoriasis in childhood and adolescence - a German expert consensusJournal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2011 648 0
Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational studyJEADV. Journal of the European Academy of Dermatology and Venereology
accessLevelRestricted
2011 542 0
Summary of minutes of the GRAPPA meeting adjacent to the American Academy of Dermatology 67th Annual MeetingJournal of rheumatology
accessLevelRestricted
2011 536 0
Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trialArchives of dermatological research
accessLevelRestricted
2011 656 0
The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidityExperimental dermatology
accessLevelRestricted
2011 643 0
Low allergenic potential with fondaparinux: results of a prospective investigationMayo Clinic proceedings
accessLevelRestricted
2010 561 0
Anti-inflammatory effects of the GABA(B) receptor agonist baclofen in allergic contact dermatitisExperimental dermatology
accessLevelRestricted
2010 695 0
Evidence-based (S3) guideline for the treatment of psoriasis vulgaris - Update: "Therapeutic options" and "Efalizumab"Journal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2010 622 0
Platelet P-selectin reflects a state of cutaneous inflammation: possible application to monitor treatment efficacy in psoriasisExperimental dermatology
accessLevelRestricted
2010 596 0
EADV preceptorship: advances in dermatologyJEADV. Journal of the European Academy of Dermatology and Venereology
accessLevelRestricted
2010 637 0
ADAM15 expression is downregulated in melanoma metastasis compared to primary melanomaBiochemical and biophysical research communications
accessLevelRestricted
2010 641 0
Heparin-induced non-necrotizing skin lesions: rarely associated with heparin-induced thrombocytopeniaJournal of thrombosis and haemostasis
accessLevelRestricted
2010 643 0
Platelet, not endothelial, P-selectin expression contributes to generation of immunity in cutaneous contact hypersensitivityThe American journal of pathology
accessLevelRestricted
2010 590 0
Juvenile psoriasis and its clinical management: a European expert group consensusJournal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2010 574 0
Managing comorbid disease in patients with psoriasisBMJ. British medical journal
2010 623 0
Immature mast cells exhibit rolling and adhesion to endothelial cells and subsequent diapedesis triggered by E- and P-selectin, VCAM-1 and PECAM-1Experimental dermatology
accessLevelRestricted
2010 626 0
Constitutive and functionally relevant expression of JAM-C on plateletsThrombosis and haemostasis
accessLevelRestricted
2010 584 0
Therapieempfehlungen fur PsoriasisarthritisZeitschrift für Rheumatologie
accessLevelRestricted
2009 588 0
PS3, a semisynthetic beta-1,3-glucan sulfate, diminishes contact hypersensitivity responses through inhibition of L- and P-selectin functionsJournal of investigative dermatology
accessLevelRestricted
2009 502 0
Managing comorbidities in psoriasisActas dermo-sifiliográficas
2009 588 0
Psoriasis--a systemic inflammatory disorder: clinic, pathogenesis and therapeutic perspectivesJournal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2009 553 0
Treatment recommendations for psoriatic arthritisAnnals of the rheumatic diseases
accessLevelRestricted
2009 547 1
Junctional adhesion molecule (JAM)-B supports lymphocyte rolling and adhesion through interaction with alpha4beta1 integrinImmunology
accessLevelRestricted
2009 648 0
Incidence and causes of heparin-induced skin lesionsCMAJ. Canadian Medical Association journal
accessLevelRestricted
2009 585 0
Ausdauer-Leistungsfahigkeit von Triathlon-Athleten mit Typ-1-DiabetesDeutsche Medizinische Wochenschrift
2009 633 0
Komorbiditaten bei Psoriasis vulgarisDer Hautarzt
accessLevelRestricted
2009 683 0
Computer-aided analysis of cell interactions under dynamic flow conditionsExperimental dermatology
accessLevelRestricted
2009 517 0
Research in practice: the systemic aspects of psoriasisJournal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2008 528 0
Dimethylfumarate reduces leukocyte rolling in vivo through modulation of adhesion molecule expressionJournal of investigative dermatology
accessLevelRestricted
2008 617 0
Tolerance of fondaparinux in patients with generalized contact dermatitis to heparinJEADV. Journal of the European Academy of Dermatology and Venereology
accessLevelRestricted
2008 609 0
The influence of heparin's molecular weight and the incidence of delayed type hypersensitivity reactions revisited; in response to Grims et al., Br J Dermatol 2007; 157:514-17British journal of dermatology
accessLevelRestricted
2008 583 0
Initiative for quality in psoriasis and psoriatic arthritisJournal of rheumatology
accessLevelRestricted
2008 526 0
Cardiovascular morbidity in psoriasis: epidemiology, pathomechanisms, and clinical consequencesGiornale italiano di dermatologia e venereologia
2008 464 0
Specific TRPC6 channel activation, a novel approach to stimulate keratinocyte differentiationThe Journal of biological chemistry
accessLevelRestricted
2008 618 0
Psoriasis: a possible risk factor for development of coronary artery calcificationBritish journal of dermatology
accessLevelRestricted
2007 557 0
P-selectin: a common therapeutic target for cardiovascular disorders, inflammation and tumour metastasisExpert opinion on therapeutic targets
accessLevelRestricted
2007 652 0
Psoriasis and risk of myocardial infarctionJAMA
accessLevelRestricted
2007 544 0
Psoriasis patients show signs of insulin resistanceBritish journal of dermatology
accessLevelRestricted
2007 587 0
Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functionsHaematologica
accessLevelRestricted
2007 583 0
Quality indicators in psoriatic arthritisClinical and Experimental Rheumatology
2007 475 0
Assessment of publications using methods of evidence-based medicine: an introduction using a dermatological clinical studyJournal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2007 557 0
Diminished lymphocyte adhesion and alleviation of allergic responses by small-molecule- or antibody-mediated inhibition of L-selectin functionsJournal of investigative dermatology
accessLevelRestricted
2007 529 0
Cost-effectiveness of psoriasis therapy with etanercept in GermanyJournal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2007 578 0
Kutane Botryomykose. Eine selten diagnostizierte bakterielle Infektion der HautDer Hautarzt
accessLevelRestricted
2007 613 0
Efalizumab in the treatment of psoriasisBiologics
accessLevelRestricted
2007 509 0
German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)Archives of dermatological research
accessLevelRestricted
2007 751 0
Animal models of psoriasisClinics in dermatology
accessLevelRestricted
2007 526 0
Evidence-based (S3) guidelines for the treatment of psoriasis vulgarisJournal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2007 614 0
Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs): a systematic structured review of the literatureArchives of dermatological research
accessLevelRestricted
2007 632 0
Psoriasis-SCID-Maus-ModellDer Hautarzt
accessLevelRestricted
2006 629 1
Therapie der Psoriasis vulgaris mit EfalizumabJournal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2006 561 0
Eukaryotic expression of the broad-spectrum chemokine receptor antagonist vMIP-II and its effects on T-cell function in vitro and in vivoExperimental dermatology
accessLevelRestricted
2006 637 0
The influence of various structural parameters of semisynthetic sulfated polysaccharides on the P-selectin inhibitory capacityBiochemical pharmacology
accessLevelRestricted
2006 538 0
Papeln am rechten Unterschenkel eines afrikanischen MadchensJournal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2006 564 0
Management of cutaneous type IV hypersensitivity reactions induced by heparinThrombosis and haemostasis
accessLevelRestricted
2006 538 0
Structure-function relation of efomycines, a family of small-molecule inhibitors of selectin functionsJournal of investigative dermatology
accessLevelRestricted
2006 601 0
Structural requirements of heparin and related molecules to exert a multitude of anti-inflammatory activitiesMini-reviews in medical chemistry
2006 527 0
Interactive large-group teaching in a dermatology courseMedical teacher
accessLevelRestricted
2006 603 0
Biologic therapies for psoriasis. A systematic reviewJournal of rheumatology
accessLevelRestricted
2006 556 0
The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivoThrombosis and haemostasis
accessLevelRestricted
2006 585 0
Leukocyte adhesion: a suitable target for anti-inflammatory drugsCurrent pharmaceutical design
2006 497 0
Chronic venous insufficiency - a potential trigger for localized sclerodermaJEADV. Journal of the European Academy of Dermatology and Venereology
accessLevelRestricted
2006 616 0
Recommendations for the use of etanercept in psoriasis: a European dermatology expert group consensusJEADV. Journal of the European Academy of Dermatology and Venereology
accessLevelRestricted
2006 613 0
S3-Leitlinie zur Therapie der Psoriasis vulgarisJournal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2006 615 0
Therapie der Psoriasis-Arthritis und der Psoriasis vulgaris mit InfliximabJournal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2006 556 0
PsoriasisThe New England journal of medicine
accessLevelRestricted
2005 495 1
Leukocyte extravasation as a target for anti-inflammatory therapy - Which molecule to choose?Experimental dermatology
accessLevelRestricted
2005 572 0
Treatment of psoriasis with alefacept in patients with hepatitis C infection: a report of two casesBritish journal of dermatology
accessLevelRestricted
2005 551 0
Therapie der Psoriasis vulgaris und Psoriasis--Arthritis mit EtanerceptJournal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2005 588 1
Eosinophilic cellulitis (Wells' syndrome) associated with colon carcinomaJournal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2005 564 0
Junctional adhesion molecules (JAM)-B and -C contribute to leukocyte extravasation to the skin and mediate cutaneous inflammationJournal of investigative dermatology
accessLevelRestricted
2005 647 0
Eyelid dermatitis caused by an eyelash formerContact dermatitis
accessLevelRestricted
2005 567 0
Efficacy of the fully human monoclonal antibody MOR102 (#5) against intercellular adhesion molecule 1 in the psoriasis-severe combined immunodeficient mouse modelBritish journal of dermatology
accessLevelRestricted
2005 503 0
Safety and efficacy of alefacept in elderly patients and other special populationsJournal of drugs in dermatology
2005 510 0
Experimental approaches to lymphocyte migration in dermatology in vitro and in vivoExperimental dermatology
accessLevelRestricted
2005 556 0
Psoriasis: Clinical manifestations, pathogenesis and therapeutic perspectivesDiscovery medicine
2005 497 0
The psoriasis SCID mouse model: a tool for drug discovery?Ernst Schering Research Foundation workshop
2005 470 0
Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharidesThrombosis and haemostasis
accessLevelRestricted
2005 602 1
Complicated mycosis fungoides mimicking facial erysipelasBritish journal of dermatology
accessLevelRestricted
2005 544 0
Toleranz von Coxiben bei Intoleranz gegenuber nicht-steroidalen Antirheumatika (NSAR)Deutsche Medizinische Wochenschrift
2005 641 0
Fixed drug eruption caused by articainAllergy
accessLevelRestricted
2004 476 0
Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion moleculesJournal of investigative dermatology
accessLevelRestricted
2004 588 0
The alpha-defensins HNP-1 and HNP-2 are dominant self-peptides presented by HLA class-II molecules in lesional psoriatic skinEJD. European journal of dermatology
accessLevelRestricted
2004 499 1
Biological therapies in the systemic management of psoriasis: International Consensus ConferenceBritish journal of dermatology
accessLevelRestricted
2004 590 0
Neue Therapieoption fur Problempatienten. Was bringen "Biologics" bei Psoriasis?MMW, Fortschritte der Medizin
2004 473 0
Targeting selectin functions in the therapy of psoriasisCurrent drug targets. Inflammation & allergy
2004 544 0
Prospective randomised comparison of traditional, personal bedside and problem-oriented practical dermatology coursesMedical education
accessLevelRestricted
2004 561 0
Druckdolente livide PapelnJournal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2004 536 0
Praaurikulare Tumore bei einem Kleinkind. Differenzialdiagnose neuroektodermaler SyndromeDer Hautarzt
accessLevelRestricted
2004 560 0
Narrowband UVB and cream psoralen-UVA combination therapy for plaque-type psoriasisJournal of the American Academy of Dermatology
accessLevelRestricted
2004 588 0
Intolerance of fondaparinux in a patient allergic to heparinsContact dermatitis
accessLevelRestricted
2004 468 0
Kind mit AtopieMMW, Fortschritte der Medizin
2004 476 0
Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasisCancer research
accessLevelRestricted
2004 569 0
Progrediente Alopezie mit JuckreizJournal der Deutschen Dermatologischen Gesellschaft
accessLevelRestricted
2004 514 0
Fehlender Bartwuchs bei einem 34jahrigen Patienten. Hypogonadotroper HypogonadismusJournal der Deutschen Dermatologischen Gesellschaft
2004 527 0
Der selektive Cyclooxygenase-2-Inhibitor Celecoxib ist ein sicheres Ausweichpraparat bei Intoleranz gegenuber nichtsteroidalen AntiphlogistikaMedizinische Klinik
accessLevelRestricted
2003 528 0
Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycansContact dermatitis
accessLevelRestricted
2003 468 0
Proteasome inhibition: a new anti-inflammatory strategyJournal of molecular medicine
accessLevelRestricted
2003 641 0
The selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticariaBritish journal of dermatology
accessLevelRestricted
2003 544 0
Interfering with leukocyte rolling--a promising therapeutic approach in inflammatory skin disorders?Trends in pharmacological sciences
accessLevelRestricted
2003 428 0
The molecular basis of lymphocyte recruitment to the skin: clues for pathogenesis and selective therapies of inflammatory disordersJournal of investigative dermatology
accessLevelRestricted
2003 554 0
Immunomodulatory drugs for psoriasisBMJ. British medical journal
accessLevelPublic
2003 588 290
Efficacy of dexpanthenol in skin protection against irritation: a double-blind, placebo-controlled studyContact dermatitis
accessLevelRestricted
2003 606 0
Effects of rofecoxib, celecoxib, and parecoxib on anti-IgE-induced histamine release from human skin mast cells and basophilsAllergy
accessLevelRestricted
2003 565 0
Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu modelThe Journal of clinical investigation
accessLevelRestricted
2002 608 0
Positive patch test reactions to celecoxib may be due to irritation and do not correlate with the results of oral provocationContact dermatitis
accessLevelRestricted
2002 519 0
Narrowband UV-B phototherapy in the treatment of cutaneous graft versus host diseaseTransplantation
accessLevelRestricted
2002 590 0
Urticaria associated with a small cell carcinoma of the lungCutis
2002 482 0
Decorative cosmetics improve the quality of life in patients with disfiguring skin diseasesEJD. European journal of dermatology
2002 537 0
Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammationNature medicine
accessLevelRestricted
2002 550 0
Reproducible identification of the causative drug of a fixed drug eruption by oral provocation and lesional patch testingContact dermatitis
accessLevelRestricted
2002 468 0
Allergic contact dermatitis from black cumin (Nigella sativa) oil-containing ointmentContact dermatitis
accessLevelRestricted
2002 561 0
Tolerance to a group C corticosteroid systemically in a patient with delayed-type hypersensitivity to group A systemic corticosteroidsContact dermatitis
accessLevelRestricted
2002 569 0
Cathepsin S activity is detectable in human keratinocytes and is selectively upregulated upon stimulation with interferon-gammaJournal of investigative dermatology
accessLevelRestricted
2002 573 0
Monitoring of phagocytic activity in histiocytic cytophagic panniculitisJournal of the American Academy of Dermatology
accessLevelRestricted
2001 584 0
Antibodies to desmogleins 1 and 3, but not to BP180, induce blisters in human skin grafted onto SCID miceJournal of pathology
accessLevelRestricted
2001 545 0
Vertraglichkeit des selektiven Cyclooxygenase-2-Inhibitors Rofecoxib bei Intoleranz gegenuber nicht-steroidalen AntiphlogistikaDeutsche Medizinische Wochenschrift
2001 574 0
Mycophenolate mofetil is effective in the treatment of atopic dermatitisArchives of dermatology
accessLevelRestricted
2001 524 0
The Western blot is a highly sensitive and efficient technique in diagnosing allergy to wasp venomClinical and experimental allergy
accessLevelRestricted
2001 542 0
Calcipotriol solution for the treatment of scalp psoriasis: evaluation of efficacy, safety and acceptance in 3,396 patientsDermatology
accessLevelRestricted
2001 551 0
Antagonistic effects of the staphylococcal enterotoxin a mutant, SEA(F47A/D227A), on psoriasis in the SCID-hu xenogeneic transplantation modelJournal of investigative dermatology
accessLevelRestricted
2001 594 0
Biologic effects of bacterial superantigens in a xenogeneic transplantation model for psoriasisThe Journal of investigative dermatology symposium proceedings
accessLevelRestricted
2001 565 0
Heavy naphthen oil exhibits antipsoriatic efficacy in vivo and antiproliferative as well as differentiation-inducing effects on keratinocytes in vitroArchives of dermatology
accessLevelRestricted
2000 628 0
Anaphylaxis to red currantsAllergy
accessLevelRestricted
2000 540 0
Delayed-type hypersensitivity reaction to kava-kava extractContact dermatitis
2000 578 0
Systemic photodynamic therapy is a safe and effective treatment for psoriasisArchives of dermatology
accessLevelRestricted
2000 537 0
Is psoriasis a T-cell disease?Experimental dermatology
accessLevelRestricted
2000 545 0
Expression of the basal cell adhesion molecule (B-CAM) in normal and diseased human skinJournal of cutaneous pathology
accessLevelRestricted
2000 567 0
Treatment of chronic plaque-stage psoriasis and psoriatic arthritis with mycophenolate mofetilJournal of the American Academy of Dermatology
2000 494 0
Benzoyl peroxide as a contact allergen in adhesive tapeContact dermatitis
accessLevelRestricted
1999 635 0
Allergic contact dermatitis from benzyl alcohol during topical antimycotic treatmentContact dermatitis
accessLevelRestricted
1999 583 0
Ablative techniques in Psoriasis vulgaris resistant to conventional therapiesDermatologic surgery
accessLevelRestricted
1999 596 0
Die Rolle bakterieller Superantigene in der Pathophysiologie der HautDer Hautarzt
accessLevelRestricted
1999 519 0
The SCID-hu xenogeneic transplantation model allows screening of anti-psoriatic drugsArchives of dermatological research
accessLevelRestricted
1999 495 0
Selection of conserved TCR VDJ rearrangements in chronic psoriatic plaques indicates a common antigen in psoriasis vulgarisEuropean Journal of Immunology
accessLevelRestricted
1999 595 0
The SCID-hu xenogeneic transplantation model: complex but tellingArchives of dermatological research
accessLevelRestricted
1999 588 0
Occupational protein contact dermatitis caused by meat and fishInternational journal of dermatology
accessLevelRestricted
1998 523 0
The T-cell receptor Vbeta repertoire of nickel-specific T cellsArchives of dermatological research
accessLevelRestricted
1998 499 0
Identification of HLA-DR and -DQ alleles conferring susceptibility to pollen allergy and pollen associated food allergyClinical and experimental allergy
accessLevelRestricted
1998 617 0
Delayed-type reactivity to calcipotriol without cross-sensitization to tacalcitolContact dermatitis
accessLevelRestricted
1997 543 0
Graft persistence in animal models of psoriasisNature medicine
accessLevelRestricted
1997 505 0
Association between interleukin-1 receptor antagonist (IL-1ra) gene polymorphism and early and late-onset psoriasisBritish journal of dermatology
accessLevelRestricted
1997 478 0
Leg ulcers in Klinefelter's syndrome--further evidence for an involvement of plasminogen activator inhibitor-1British journal of dermatology
accessLevelRestricted
1997 567 0
Allergic contact dermatitis from diphenylthiourea in a wet suitContact dermatitis
accessLevelRestricted
1997 491 0
Alopecia areata but not androgenetic alopecia is characterized by a restricted and oligoclonal T-cell receptor-repertoire among infiltrating lymphocytesJournal of cutaneous pathology
accessLevelRestricted
1997 630 0
Superantigens but not mitogens are capable of inducing upregulation of E-selectin ligands on human T lymphocytesExperimental dermatology
accessLevelRestricted
1997 570 0
Induction of psoriasiform inflammation by a bacterial superantigen in the SCID-hu xenogeneic transplantation modelJournal of cutaneous pathology
accessLevelRestricted
1997 575 0
Psoriasis im TiermodellDer Hautarzt
accessLevelRestricted
1997 513 1
Nagellack-Allergie. Eine wichtige Differentialdiagnose bei KontaktdermatitisDeutsche Medizinische Wochenschrift
1997 739 0
Die photodynamische Therapie an der Schwelle zur klinischen Anwendung bei disseminierten DermatosenDer Hautarzt
1996 473 0
Type-IV hypersensitivity to topical estradiol in a patient tolerant to it orallyContact dermatitis
1996 509 0
Intolerance to sodium metabisulfite in beerAllergy
1996 541 0
Mensch-zu-Maus Xenotransplantationsmodelle komplementieren Transgene und knock-out Mause. Stellungnahme zur Arbeit von K. Sellheyer: Transgene Mause als Modelle fur HautkrankheitenDer Hautarzt
1996 521 0
Tolerance to intravenous administration of heparin and heparinoid in a patient with delayed-type hypersensitivity to heparins and heparinoidsContact dermatitis
1996 533 0
Clinical and pathophysiological aspects of hydroxyethyl starch-induced pruritus: evaluation of 96 casesDermatology
1996 577 0
Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DRB1*0701-DQA1*0201-DQB1*0303: a population- and family-based studyJournal of investigative dermatology
accessLevelRestricted
1996 513 0
Psoriasis and bacterial superantigens--formal or causal correlation?Trends in microbiology
accessLevelRestricted
1996 490 0
Pulling the trigger on psoriasisNature
accessLevelRestricted
1996 575 0
Ethanol metabolite acetic acid as causative agent for type-1 hypersensitivity-like reactions to alcoholic beveragesClinical and experimental allergy
accessLevelRestricted
1996 592 0
Comparison of sensitivity towards photodynamic therapy of cutaneous resident and infiltrating cell types in vitroLasers in surgery and medicine
accessLevelRestricted
1996 567 0
T-cell receptor beta variable region (V beta) usage in cutaneous T-cell lymphomas (CTCL) in comparison to normal and eczematous skinJournal of cutaneous pathology
1996 605 0
The superantigen exfoliative toxin induces cutaneous lymphocyte-associated antigen expression in peripheral human T lymphocytesImmunology letters
accessLevelRestricted
1996 637 0
Influence of activation and differentiation of cells on the effectiveness of photodynamic therapyActa dermato-venereologica
1995 406 0
T-cell-receptor repertoire in chronic plaque-stage psoriasis is restricted and lacks enrichment of superantigen-associated V beta regionsJournal of investigative dermatology
accessLevelRestricted
1995 554 0
A subset of macrophages located along the basement membrane ("lining cells") is a characteristic histopathological feature of psoriasisThe American journal of dermatopathology
1995 530 0
Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivoArchives of dermatological research
1994 569 0
Treatment of psoriasis by topical photodynamic therapy with polychromatic lightLancet
1994 492 0
Psoriasiform architecture of murine epidermis overlying human psoriatic dermis transplanted onto SCID miceArchives of dermatological research
1994 596 0
Predominant usage of distinct T-cell receptor V beta regions by epidermotropic T cells in psoriasisExperimental dermatology
1994 570 0
In vitro and in vivo effects of photodynamic therapy in cutaneous T cell lymphomaActa dermato-venereologica
1994 548 0
Analysis of TAP2 and HLA-DP gene polymorphism in psoriasisHuman immunology
accessLevelRestricted
1994 589 0
Differential expression of heat shock protein 70 (HSP70) and heat shock cognate protein 70 (HSC70) in human epidermisArchives of dermatological research
1994 524 0
Primary subcutaneous leiomyosarcoma exhibiting the characteristic immunophenotype positive for vimentin and desminThe Journal of dermatologic surgery and oncology
1994 591 0
Evidence for a pathway independent from 2'-deoxyguanosine and reversible by IL-2 by which purine nucleoside phosphorylase inhibitors block T-cell proliferationScandinavian journal of immunology
1994 561 0
Clonal disease in early cutaneous T-cell lymphomaDermatologic clinics
1994 499 0
Discrimination between immunoaccessory and phagocytic monocytes/macrophages of the skin in paraffin-embedded tissue by the monoclonal antibody Ki-M1PBritish journal of dermatology
1993 509 0
Osteoma cutis. Multiple miliare Osteome des GesichtsDer Hautarzt
1993 525 0
Oligonucleotide typing reveals association of type I psoriasis with the HLA-DRB1*0701/2, -DQA1*0201, -DQB1*0303 extended haplotypeJournal of investigative dermatology
accessLevelRestricted
1993 559 0
The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognitionThe Journal of immunology
accessLevelRestricted
1993 580 0
A majority of proliferating T cells in cutaneous malignant T cell lymphomas may lack the high affinity IL-2 receptor (CD25)Archives of dermatological research
1993 573 0
Role of beta 1-integrins in epidermotropism of malignant T cellsThe American journal of pathology
accessLevelRestricted
1992 546 0
Demonstration of clonal disease in early mycosis fungoidesThe American journal of dermatopathology
1992 547 0
Differential expression of adhesion molecules on infiltrating cells in inflammatory dermatosesJournal of the American Academy of Dermatology
accessLevelRestricted
1992 493 0
Excess beta 2 microglobulin promoting functional peptide association with purified soluble class I MHC moleculesNature
accessLevelRestricted
1991 495 0
Type I and type II psoriasis show a similar usage of T-cell receptor variable regionsJournal of investigative dermatology
accessLevelRestricted
1991 573 0
Plasma cells in the dermal infiltrate of mycosis fungoides are of polyclonal originActa dermato-venereologica
1989 542 0
C-type particles are inducible in Se-Ax, a continuous T-cell line from a patient with Sezary's syndromeArchives of dermatological research
1988 534 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack